Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

John Paulson May Pressure Syngenta AG (SYT) To Sell To Monsanto Company (MON)

Page 1 of 2

John Paulson of Paulson & Co may start pushing Syngenta AG (ADR) (NYSE:SYT) to accept an acquisition offer by Monsanto Company (NYSE:MON), according to a report from Reuters. Citing unnamed sources familiar with the matter, the news organization said that Paulson & Co has taken a stake in Syngenta AG, which previously snubbed a $45-billion offer from Monsanto in May, saying then that the deal undervalued its business. The Swiss pesticide maker rejected a second offer in June, telling Monsanto that the $2 billion it was offered to receive if the deal was accepted by the firm, but either stopped by regulators or then discontinued by Monsanto upon examining Syngenta’s books, was low. Syngenta has not let Monsanto access its business data.Syngenta AG (SYT), NYSE:SYT, John Paulson, Paulson & Co,

Paulson, the billionaire activist investor infamous for betting on a housing bubble in the U.S. before the market crash, reportedly began building up his stake in Syngenta last month. Swiss law only requires disclosure of stakes in public companies once stakes reach 3% of all shares. The Reuters report about a possible hostile bid by Monsanto Company (NYSE:MON) supported by Paulson & Co comes after Bloomberg previously reported that Paulson & Co was acquiring shares of Syngenta AG (ADR) (NYSE:SYT) which, according to their source, could make the firm among the top 20 largest stakeholders of Syngenta.

John Paulson
John Paulson
Paulson & Co

However, in a separate Reuters report, Monsanto Company (NYSE:MON) President and COO Brett Begemann said that they would rather have a negotiated deal with Syngenta AG (ADR) (NYSE:SYT), since making a hostile bid without seeing business data is “not a very compelling idea”. Furthermore, while Begemann said they have not ruled out a hostile bid, it is “a ways out,” he told Reuters.

The development also comes as Syngenta AG (ADR) (NYSE:SYT) experienced bearish sentiment from hedge funds in the first quarter. Despite the stock growing in value by 5.56% in the first quarter, the total value of holdings among the hedge funds we track who were still long in Syngenta by March 31 plunged by 28.52% versus the end of 2014, to $63.26 million. Furthermore, at the end of the first quarter, a total of nine of the hedge funds tracked by Insider Monkey held long positions in this stock. There were 12 hedge funds in our database with Syngenta positions at the end of the previous quarter.

Let’s first take a step back and analyze how tracking hedge funds can help an everyday investor. Through our research, we discovered that a portfolio of the 15 most popular small-cap picks of hedge funds beat the S&P 500 Total Return Index by nearly a percentage point per month on average between 1999 and 2012. On the other hand, the most popular large-cap picks of hedge funds underperformed the same index by seven basis points per month during the same period. This is likely a surprise to many investors, who think of small-caps as risky, unpredictable stocks and put more faith in large-cap stocks. In forward tests since August 2012, these top small-cap stocks beat the market by an impressive 80 percentage points, returning over 139% (read the details here). Hence, a retail investor needs to isolate himself from the herd and take advantage of the best growth opportunities in the market by concentrating on small-cap stocks.

At Insider Monkey, we also follow company insiders of companies like Syngenta AG (ADR) (NYSE:SYT) and see whether these insiders have recently purchased or sold stock in the company. This tells us if company insiders are willing to risk their money on their firm’s stock or whether they are cashing in. It should be noted, however, that there were no recorded purchases or sales of shares by insiders of Syngenta through July 16.

Now let’s take a look at the latest hedge fund trades regarding Syngenta AG on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!